{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:28:53Z","timestamp":1772191733918,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s10654-012-9702-x","type":"journal-article","created":{"date-parts":[[2012,6,18]],"date-time":"2012-06-18T09:53:30Z","timestamp":1340013210000},"page":"431-438","source":"Crossref","is-referenced-by-count":15,"title":["Aspirin in the primary prevention of cardiovascular disease in the Women\u2019s Health Study: Effect of noncompliance"],"prefix":"10.1007","volume":"27","author":[{"given":"Nancy R.","family":"Cook","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen R.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie E.","family":"Buring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,15]]},"reference":[{"key":"9702_CR1","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/bmj.296.6618.320","volume":"296","author":"Antiplatelet Trialists\u2019 Collaboration","year":"1988","unstructured":"Antiplatelet Trialists\u2019 Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet therapy. Brit Med J. 1988;296:320\u201331.","journal-title":"Brit Med J"},{"key":"9702_CR2","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","volume":"351","author":"L Hansson","year":"1998","unstructured":"Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998;351:1755\u201362.","journal-title":"Lancet"},{"key":"9702_CR3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(97)11475-1","volume":"351","author":"The Medical Research Council\u2019s General Practice Research Framework","year":"1998","unstructured":"The Medical Research Council\u2019s General Practice Research Framework. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. Lancet. 1998;351:233\u201341.","journal-title":"Lancet"},{"key":"9702_CR4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198907203210301","volume":"321","author":"The Steering Committee of the Physicians\u2019 Health Study Research Group","year":"1989","unstructured":"The Steering Committee of the Physicians\u2019 Health Study Research Group. Final report on the aspirin component of the ongoing Physicians\u2019 Health Study. Steering Committee of the Physicians\u2019 Health Study Research Group [see comments]. N Engl J Med. 1989;321:129\u201335.","journal-title":"N Engl J Med"},{"key":"9702_CR5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/bmj.296.6618.313","volume":"296","author":"R Peto","year":"1988","unstructured":"Peto R, Gray R, Collins R, et al. Randomised trial of prophylactic daily aspirin in British male doctors. Brit Med J. 1988;296:313\u20136.","journal-title":"Brit Med J"},{"key":"9702_CR6","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa050613","volume":"352","author":"PM Ridker","year":"2005","unstructured":"Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005;352:1293\u2013304.","journal-title":"N Engl J Med"},{"key":"9702_CR7","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","volume":"373","author":"Antithrombotic Trialists\u2019 (ATT) Collaboration","year":"2009","unstructured":"Antithrombotic Trialists\u2019 (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomized trials. Lancet. 2009;373:1849\u201360.","journal-title":"Lancet"},{"key":"9702_CR8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-136-2-200201150-00015","volume":"136","author":"U.S. Preventive Services Task Force","year":"2002","unstructured":"U.S. Preventive Services Task Force. Aspirin for the primary prevention of cardiovascular events: recommendation and rationale. Ann Intern Med. 2002;136:157\u201360.","journal-title":"Ann Intern Med"},{"key":"9702_CR9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","volume":"11","author":"JM Robins","year":"2000","unstructured":"Robins JM, Hernan M, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11:550\u201360.","journal-title":"Epidemiology"},{"key":"9702_CR10","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/aje\/155.11.1045","volume":"155","author":"NR Cook","year":"2002","unstructured":"Cook NR, Cole SR, Hennekens CH. Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians\u2019 Health Study. Am J Epidemiol. 2002;155:1045\u201353.","journal-title":"Am J Epidemiol"},{"key":"9702_CR11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/152460900318911","volume":"9","author":"KM Rexrode","year":"2000","unstructured":"Rexrode KM, Lee IM, Cook NR, Hennekens CH, Buring JE. Baseline characteristics of participants in the Women\u2019s Health Study. J Womens Health Gend Based Med. 2000;9:19\u201327.","journal-title":"J Womens Health Gend Based Med"},{"key":"9702_CR12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.294.1.47","volume":"294","author":"NR Cook","year":"2005","unstructured":"Cook NR, Lee IM, Gaziano JM, et al. Low-dose aspirin in the primary prevention of cancer. J Am Med Assoc. 2005;294:47\u201355.","journal-title":"J Am Med Assoc"},{"key":"9702_CR13","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling survival data: extending the cox model","author":"TM Therneau","year":"2000","unstructured":"Therneau TM, Grambsch PM. Modeling survival data: extending the cox model. New York: Springer; 2000."},{"key":"9702_CR14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1005285815569","volume":"121","author":"JM Robins","year":"1999","unstructured":"Robins JM. Association, causation, and marginal structural models. Synthese. 1999;121:151\u201379.","journal-title":"Synthese"},{"key":"9702_CR15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00001648-200009000-00012","volume":"11","author":"M Hern\u00e1n","year":"2000","unstructured":"Hern\u00e1n M, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology. 2000;11:561\u201370.","journal-title":"Epidemiology"},{"key":"9702_CR16","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/sim.4780091214","volume":"9","author":"RB D\u2019Agostino","year":"1990","unstructured":"D\u2019Agostino RB, Lee ML, Belanger AJ, Cupples LA, Anderson K, Kannel WB. Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med. 1990;9:1501\u201315.","journal-title":"Stat Med"},{"key":"9702_CR17","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/aje\/kwn164","volume":"168","author":"SR Cole","year":"2008","unstructured":"Cole SR, Hern\u00e1n MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008;168:656\u201364.","journal-title":"Am J Epidemiol"},{"key":"9702_CR18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"Antithrombotic Trialists\u2019 Collaboration","year":"2002","unstructured":"Antithrombotic Trialists\u2019 Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Brit Med J. 2002;324:71\u201386.","journal-title":"Brit Med J"},{"key":"9702_CR19","doi-asserted-by":"crossref","first-page":"396","DOI":"10.7326\/0003-4819-150-6-200903170-00008","volume":"150","author":"U.S. Preventive Services Task Force","year":"2009","unstructured":"U.S. Preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;150:396\u2013404.","journal-title":"Ann Intern Med"},{"key":"9702_CR20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/dc08-1206","volume":"32","author":"AD Pradhan","year":"2009","unstructured":"Pradhan AD, Cook NR, Manson JE, Ridker PM, Buring JE. A randomized trial of low-dose aspirin in the prevention of clinical type 2 diabetes in women. Diab Care. 2009;32:3\u20138.","journal-title":"Diab Care"},{"key":"9702_CR21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.0333-1024.2001.00194.x","volume":"21","author":"IM Bense\u00f1or","year":"2001","unstructured":"Bense\u00f1or IM, Cook NR, Lee IM, Chown MJ, Hennekens CH, Buring JE. Low-dose aspirin for migraine prophylaxis in women. Cephalalgia. 2001;21:175\u201383.","journal-title":"Cephalalgia"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-012-9702-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10654-012-9702-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-012-9702-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:42:36Z","timestamp":1559234556000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10654-012-9702-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["9702"],"URL":"https:\/\/doi.org\/10.1007\/s10654-012-9702-x","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"value":"0393-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}